1. PIN-A1, a novel Casein Kinase 1α-selective molecular glue degrader, demonstrates strong antitumor activity via activation of the p53 pathway in preclinical models of AML with a favorable safety profile. (October 2022) Authors: Jung, J.; Park, J.; Mohanty, S.; Kim, Y.; Levy, D.; King-Underwood, J.; Deninno, M.; Baek, J.; Choi, W.; Lee, S.; Lee, D.; Kang, H.; Brotz, T.; Terrett, N.; Jo, H.; Kim, Y. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗